(Reuters) – BioTime Inc said on Wednesday its Renevia system succeeded in meeting the main goal of a pivotal European trial for facial wasting associated with treatment for HIV, putting it on track to file for European approval this year.
(Reuters) – A synthetic version of a medicine traditionally extracted from chili plant relieved knee pain among osteoarthritis patients for up to six months, data showed, bringing Centrexion Therapeutics a step closer to developing a safe and effective analgesic.
LONDON (Reuters) – People who are aged 75 or older and take aspirin daily to ward off heart attacks face a significantly elevated risk of serious or even fatal bleeding and should be given heartburn drugs to minimize the danger, a 10-year study has found.
WASHINGTON (Reuters) – U.S. President Donald Trump on Tuesday urged Senate Republicans to pass a “generous” replacement program for Obamacare, as the Senate struggled to produce an alternative to the healthcare law.
(Reuters Health) – Drones may be able to rush emergency defibrillators to patients in cardiac arrest faster than traditional emergency medical services (EMS), potentially improving survival odds, a small Swedish experiment suggests.
(Reuters Health) – Children born to mothers who experienced fever, especially multiple fevers, during the second trimester of pregnancy are at increased risk for developing autism spectrum disorder (ASD), a new study suggests.
NEW YORK (Reuters) – The U.S. Food & Drug Administration on Tuesday delayed indefinitely implementation of a new nutrition facts label that would enlarge calorie counts, itemize added sugar and bring serving sizes in line with actual average portions.